I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 34% ± 13% | |
| epithelial cell of proximal tubule | 5 studies | 19% ± 3% | |
| endothelial cell | 5 studies | 23% ± 8% | |
| natural killer cell | 5 studies | 18% ± 1% | |
| fibroblast | 4 studies | 22% ± 7% | |
| abnormal cell | 4 studies | 20% ± 5% | |
| pancreatic A cell | 3 studies | 18% ± 3% | |
| conventional dendritic cell | 3 studies | 27% ± 8% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| smooth muscle cell | 3 studies | 18% ± 3% | |
| ciliated cell | 3 studies | 24% ± 4% | |
| dendritic cell | 3 studies | 32% ± 7% | |
| goblet cell | 3 studies | 20% ± 4% | |
| basal cell | 3 studies | 31% ± 12% | |
| plasmacytoid dendritic cell | 3 studies | 22% ± 3% | |
| hepatocyte | 3 studies | 31% ± 21% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
